GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Selling and Marketing Expense

LSL Pharma Group (TSXV:LSL) Selling and Marketing Expense : C$0.05 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. LSL Pharma Group's Selling and Marketing Expense for the three months ended in Dec. 2024 was C$0.00 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.05 Mil.

LSL Pharma Group Selling and Marketing Expense Historical Data

The historical data trend for LSL Pharma Group's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Selling and Marketing Expense Chart

LSL Pharma Group Annual Data
Trend Sep20 Dec21 Dec22 Dec23 Dec24
Selling and Marketing Expense
0.22 0.22 0.13 0.12 -

LSL Pharma Group Quarterly Data
Sep20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.03 0.02 - -

LSL Pharma Group Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LSL Pharma Group Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Selling and Marketing Expense
Comparable Companies
XCNQ:EPIC XCNQ:AYR.A TSXV:DB TSX:LABS XCNQ:IAN XCNQ:FNT.U XCNQ:INNO XCNQ:VEXT XCNQ:GWAY TSXV:ROMJ ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
540 d’Avaugour Street, Suite 1800, Boucherville, QC, CAN, J4B 0G6
Website
https://www.laboratoirelsl.com
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group Headlines

No Headlines